AR003967A1 - (22R) -N- (1,1,1-TRIFLUORO-2-PHENYLPROP-2-IL) -3-OXO-4-AZA-5ALFA- ANDROST-1-ENO-17BETA-CARBOXAMIDE EPIMERES, A PROCESS FOR YOUR PREPARATION AND A PHARMACEUTICAL COMPOSITION THAT UNDERSTAND THEM. - Google Patents

(22R) -N- (1,1,1-TRIFLUORO-2-PHENYLPROP-2-IL) -3-OXO-4-AZA-5ALFA- ANDROST-1-ENO-17BETA-CARBOXAMIDE EPIMERES, A PROCESS FOR YOUR PREPARATION AND A PHARMACEUTICAL COMPOSITION THAT UNDERSTAND THEM.

Info

Publication number
AR003967A1
AR003967A1 ARP960103652A AR10365296A AR003967A1 AR 003967 A1 AR003967 A1 AR 003967A1 AR P960103652 A ARP960103652 A AR P960103652A AR 10365296 A AR10365296 A AR 10365296A AR 003967 A1 AR003967 A1 AR 003967A1
Authority
AR
Argentina
Prior art keywords
17beta
androst
phenylprop
aza
carboxamide
Prior art date
Application number
ARP960103652A
Other languages
Spanish (es)
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of AR003967A1 publication Critical patent/AR003967A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a los epímeros:(22R)-N-(1,1,1-trifluoro-2- fenilprop-2-il)-3-oxo-4-aza-5alfa-androst-1-eno-17beta-carboxamida, y (22S)-N-(1,1,1-trifluoro-2-fenilprop-2-il)-3-oxo-4-aza-5alfa-androst-1-eno-17beta- carboxamida, útiles como inhibidores de la enzima 5-reductasa de testosterona,procesos para su preparación y composiciones farmacéuticas que los contienen. Dichos epímeros responden a las fórmulas (I) y (II).The present invention relates to the epimers: (22R) -N- (1,1,1-trifluoro-2-phenylprop-2-yl) -3-oxo-4-aza-5alpha-androst-1-ene-17beta -carboxamide, and (22S) -N- (1,1,1-trifluoro-2-phenylprop-2-yl) -3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide, useful as testosterone 5-reductase enzyme inhibitors, processes for their preparation and pharmaceutical compositions containing them. Said epimers respond to formulas (I) and (II).

ARP960103652A 1995-07-21 1996-07-19 (22R) -N- (1,1,1-TRIFLUORO-2-PHENYLPROP-2-IL) -3-OXO-4-AZA-5ALFA- ANDROST-1-ENO-17BETA-CARBOXAMIDE EPIMERES, A PROCESS FOR YOUR PREPARATION AND A PHARMACEUTICAL COMPOSITION THAT UNDERSTAND THEM. AR003967A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001587A IT1275594B1 (en) 1995-07-21 1995-07-21 EPIMERS OF (22RS) -N- (1,1,1-TRIFLUORO-2-PHENYLPROP-2-IL) -3-BONE -4-AZA-5ALFA-ANDROST-1-ENE-17BETA-CARBOSSAMIDE

Publications (1)

Publication Number Publication Date
AR003967A1 true AR003967A1 (en) 1998-09-30

Family

ID=11372032

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103652A AR003967A1 (en) 1995-07-21 1996-07-19 (22R) -N- (1,1,1-TRIFLUORO-2-PHENYLPROP-2-IL) -3-OXO-4-AZA-5ALFA- ANDROST-1-ENO-17BETA-CARBOXAMIDE EPIMERES, A PROCESS FOR YOUR PREPARATION AND A PHARMACEUTICAL COMPOSITION THAT UNDERSTAND THEM.

Country Status (17)

Country Link
EP (1) EP0782582A1 (en)
JP (1) JPH10506411A (en)
KR (1) KR970706298A (en)
CN (1) CN1159195A (en)
AR (1) AR003967A1 (en)
AU (1) AU6418396A (en)
BR (1) BR9606527A (en)
CA (1) CA2199273A1 (en)
EA (1) EA199700045A1 (en)
HU (1) HUP9702465A3 (en)
IL (1) IL120343A0 (en)
IT (1) IT1275594B1 (en)
MX (1) MX9701948A (en)
NO (1) NO971196L (en)
PL (1) PL319351A1 (en)
WO (1) WO1997004002A1 (en)
ZA (1) ZA965678B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6137399A (en) * 1998-09-09 2000-03-27 Merck & Co., Inc. Method of determining and reducing the risk of bph-related urologic events
DE60018707T2 (en) * 1999-01-25 2006-02-09 Smithkline Beecham Corp. ANTI-ANDROGENES AND METHOD FOR THE TREATMENT OF DISEASES
CN100355772C (en) * 2005-12-28 2007-12-19 天津大学 Steroid compound with 5-alpha reductase active and preparation process thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216284D0 (en) * 1992-07-31 1992-09-16 Erba Carlo Spa Fluorinated 17beta-substituted 4-aza-5alpha-androstane-3-one derivatives

Also Published As

Publication number Publication date
NO971196D0 (en) 1997-03-14
AU6418396A (en) 1997-02-18
CA2199273A1 (en) 1997-02-06
PL319351A1 (en) 1997-08-04
WO1997004002A1 (en) 1997-02-06
ITMI951587A0 (en) 1995-07-21
ITMI951587A1 (en) 1997-01-21
HUP9702465A3 (en) 1998-11-30
NO971196L (en) 1997-03-14
HUP9702465A2 (en) 1998-05-28
EA199700045A1 (en) 1997-12-30
BR9606527A (en) 1997-12-23
EP0782582A1 (en) 1997-07-09
MX9701948A (en) 1997-06-28
JPH10506411A (en) 1998-06-23
CN1159195A (en) 1997-09-10
IT1275594B1 (en) 1997-08-06
KR970706298A (en) 1997-11-03
ZA965678B (en) 1997-01-24
IL120343A0 (en) 1997-06-10

Similar Documents

Publication Publication Date Title
MX9100990A (en) MOMETASONE FUROATE MONOHYDRATE COMPOUND, THE PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS
ES2090713T3 (en) ORGANIC SALTS OF N, N'-DIACETIL-CYSTINE.
GT199900102A (en) PHENOXIPROPANOLAMINES, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2144192T3 (en) NEW DERIVATIVES OF 1-PHENYL-2-DIMETHYL-AMINO-METHYL-CICLOHEXAN-1-OL, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
MX9304756A (en) 9 - [(SUBSTITUTED GLYCLE) AMIDO] -6-DESMETIL-6-DESOXITETRACICLINAS, METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2126766T3 (en) TROPYL 7-AZAINDOL-3-ILCARBOXIAMIDES AS ANTI-TUSSIVE AGENT.
ECSP941104A (en) DERIVATIVES OF 2,6 DIAMINOPURINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
AR003220A1 (en) ACILATED MELATONIN DERIVATIVES; PHARMACEUTICAL AND COSMETIC COMPOSITION AND THE USE OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT.
ES2052603T3 (en) DERIVATIVES OF BENCIMIDAZOLE, PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM.
CU23415B7 (en) DERIVATIVES OF 2,6- QUINOLINILO AND 2,6- NAFTILO, PROCESSES FOR THEIR PREPARATION AND ITS USES
ES2111556T3 (en) NEW ALKYL-HETEROCICLIC AMINES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2178055T3 (en) SUBSTITUTED AMINIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
IT1265101B1 (en) DERIVATIVES OF 2-AMINO-4-PHENYL-4-BUTYRIC BONE ACID
MX9305364A (en) RETROVIRAL PROTEASE INHIBITING COMPOUNDS, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM.
ES2187738T3 (en) DERIVATIVES OF FLAVONAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOUNDS THAT CONTAIN THEM.
IT1259419B (en) 3-CARBOSE STEROIDS 17B - UNSATURATED SUBSTITUTES USEFUL AS INHIBITORS OF TESTOSTERONE 5 IN REDUCTASE
AR002017A1 (en) DERIVATIVES OF FENIL-4-TIAZOLES SUBSTITUTED, PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND DERIVATIVES DEFENIL-4-TIAZOLES SUBSTITUTED USED IN SUCH PROCEDURE.
ES2159054T3 (en) DI-TERC-BUTIL-PHENOLIC COMPOUNDS CONTAINING USEFUL SULFUR AS ANTI-INFLAMMATORY AGENTS.
ES2150461T3 (en) DERIVATIVES OF AMIDINOPHENYLALANINE, PROCESS FOR ITS PREPARATION, ITS EMPLOYMENT AND AGENTS THAT CONTAIN THEM AS ANTICOAGULANTS.
AR003107A1 (en) DERIVATIVES OF VITAMIN D FOR DERMATOLOGICAL USE, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND PROCEDURE FOR THE PREPARATION OF SUCH DERIVATIVES.
AR003967A1 (en) (22R) -N- (1,1,1-TRIFLUORO-2-PHENYLPROP-2-IL) -3-OXO-4-AZA-5ALFA- ANDROST-1-ENO-17BETA-CARBOXAMIDE EPIMERES, A PROCESS FOR YOUR PREPARATION AND A PHARMACEUTICAL COMPOSITION THAT UNDERSTAND THEM.
MX9307203A (en) STEROIDAL COMPOUNDS OF ACIL-3-CARBOXI-3,5-DIENO-17Ó AND 17ß-SUBSTITUTED.
UY26517A1 (en) PIRAZOLO (4,3-E) NOVEL SUBSTITUTED DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, THEIR USE AS MEDICINAL PRODUCTS AND PROCESSES TO PREPARE THEM
ES2175661T3 (en) DERIVATIVES OF ISOFLAVONA, PROCEDURES FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES2106800T3 (en) COMPOSITION CONTAINING GAMMA OCTALACTONE, FERMENTATION PROCEDURE FOR ITS PRODUCTION AND ORGANOLEPTICAL USES OF THE SAME.